Brief: Scancell Continues To Recruit To Scope Study, Which Includes Patients Treated With Scib1 As Well As iSCIB1+
July 24 (Reuters) - Scancell Holdings PLC SCLP.L :
* SCANCELL HLDS - UPDATE FROM ISCIB1+ CLINICAL ADVISORY
MEETING
* SCANCELL: CONTINUES TO RECRUIT TO SCOPE STUDY, WHICH
INCLUDES
PATIENTS TREATED WITH SCIB1 AS WELL AS ISCIB1+
Source text for Eikon: ID:nRSX5353Xa
Further company coverage: SCLP.L
((Reuters.Briefs@thomsonreuters.com;))